In 2010, Dick Cheney received an LVAD device ahead of a heart transplant, which resulted in him possibly living with no pulse ...

The FDA has approved Transcranial Magnetic Stimulation (TMS), a non-drug, magnetic pulse device, for use in teens as young as ...

Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating AFib.

The FDA has approved a Transcranial Magnetic Stimulation device to treat adolescents with severe depression, offering a ...

Data from the POWER PAD II Study presented at VIVA will support FDA 510 (k) submission in 2026 ...

Pulse Biosciences ( PLSE 3.81%) reported its first revenues, marking initial commercial adoption of its nPulse platform and ...

OAKLAND, Calif. (KGO) -- As we continue to navigate the tripledemic of COVID-19, RSV, and the flu, local health leaders are raising concerns over a key medical device that often determines if a sick ...

A Food and Drug Administration advisory committee Tuesday will take up the issue of whether pulse oximeters, the ubiquitous medical devices that became a mainstay for assessing patient oxygen levels ...

For many individuals who develop symptoms of the coronavirus, it's better to stay home than seek health care in person. But when you have a disease with so many unknowns, not having a nurse or doctor ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. In 2022, Noha Aboelata noticed something troubling. The founding CEO ...

A new study shows that the use of a simple maternity innovation that measures the mother's blood pressure and pulse can be ...

Early on in the COVID-19 pandemic, Kimani Toussant’s wife, an epidemiologist, brought him an article about how pulse oximeters appeared to be less accurate in people with darker skin. The small ...